Unlock stock picks and a broker-level newsfeed that powers Wall Street.
4.4100
-0.0200
(-0.45%)
At close: April 2 at 4:00:01 PM EDT
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 287,850 | 7 |
Sales | 157,895 | 1 |
Net Shares Purchased (Sold) | 129,955 | 8 |
Total Insider Shares Held | 433.03k | -- |
% Net Shares Purchased (Sold) | 42.80% | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
LEO CHANDRA P. MD Director | Purchase at price 5.84 per share. | Direct | 58,383 | Mar 24, 2025 |
JANKU FILIP Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
NICKSON PHILIP Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
DUNN EDMUND Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
CHAMPOUX JENNIFER Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
TOWNSON SHARON Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
WARMUTH MARKUS M.D. Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 2, 2025 |
VERSANT VENTURE CAPITAL VI, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 9.08 - 9.66 per share. | Indirect | 1,491,041 | Oct 29, 2024 |
VERSANT VENTURE CAPITAL VI, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 6.53 per share. | Direct | 7,395,203 | Sep 20, 2024 |
VERSANT VENTURE CAPITAL VI, L.P. Beneficial Owner of more than 10% of a Class of Security | Sale at price 6.00 - 6.16 per share. | Indirect | 3,404,791 | Sep 13, 2024 |
DUNN EDMUND Officer | Sale at price 3.83 per share. | Direct | 6,166 | Jul 5, 2024 |
DUNN EDMUND Officer | Sale at price 4.04 per share. | Direct | 4,876 | Jun 3, 2024 |
Related Tickers
TYRA Tyra Biosciences, Inc.
8.65
-0.80%
KYMR Kymera Therapeutics, Inc.
26.36
+4.46%
IPSC Century Therapeutics, Inc.
0.4697
+3.96%
TCRX TScan Therapeutics, Inc.
1.2700
0.00%
ERAS Erasca, Inc.
1.2600
+4.56%
DNTH Dianthus Therapeutics, Inc.
17.86
+6.12%
CGEM Cullinan Therapeutics, Inc.
7.82
+4.27%
OLMA Olema Pharmaceuticals, Inc.
3.3300
-0.30%
RVMD Revolution Medicines, Inc.
34.60
+2.91%
NRIX Nurix Therapeutics, Inc.
11.38
+8.69%